Excluded Evidence Could Revive Pa. Paxil Case On Appeal
A decision to bar key deposition testimony and grant the midtrial dismissal of a Pennsylvania case against GlaxoSmithKline PLC over alleged birth defects from the antidepressant Paxil could be upended on...To view the full article, register now.
Already a subscriber? Click here to view full article